Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
3,062
Views
74
CrossRef citations to date
0
Altmetric
Original Articles

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library

Jie FengDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Ting WangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Wanliang ShiDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Shuo ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
David SullivanDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
,
Paul G AuwaerterFisher Center for Environmental Infectious Diseases, School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
&
Ying ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USACorrespondence[email protected]
 show all
Pages 1-8 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Radolf JD, Caimano MJ, Stevenson B, Hu LT.Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol2012;10: 87–99.
  • Centers for Disease Control and Prevention. Lyme disease data. Atlanta: CDC, 2012.Available at http://www.cdc.gov/lyme/stats/index.html (accessed 12 April 2014).
  • Centers for Disease Control and Prevention. Post-Treatment Lyme Disease Syndrome.Atlanta: CDC, 2014.Available at: http://www.cdc.gov/lyme/postLDS/index.html (accessed 13 Apirl 2014).
  • Marques A.Chronic Lyme disease.In: Halperin JJ (ed.) Lyme disease: an evidence based approach.Oxfordshire: CABI, 2011: 248–258.
  • Wormser GP, Dattwyler RJ, Shapiro ED et al.The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis2006;43: 1089–1134.
  • Klempner MS, Baker PJ, Shapiro ED et al.Treatment trials for post-Lyme disease symptoms revisited. Am J Med2013;126: 665–669.
  • Nowakowski J, Nadelman RB, Sell R et al.Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med2003;115: 91–96.
  • Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA.Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest2012;122: 2652–2660.
  • Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW.Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother2008;52: 1728–1736.
  • Diterich I, Rauter C, Kirschning CJ, Hartung T.Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun2003;71: 3979–3987.
  • Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ.Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother2010;54: 643–651.
  • Embers ME, Barthold SW, Borda JT et al.Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One2012;7: e29914.
  • Hodzic E, Imai D, Feng S, Barthold SW.Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice. PLoS One2014;9: e86907.
  • Straubinger RK, Summers BA, Chang YF, Appel MJ.Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol1997;35: 111–116.
  • Wormser GP, Baker PJ, O'Connell S, Pachner AR, Schwartz I, Shapiro ED.Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design. Vector Borne Zoonotic Dis2012;12: 535–538.
  • Wormser GP, Schwartz I.Antibiotic treatment of animals infected with Borrelia burgdorferi. Clin Microbiol Rev2009;22: 387–395.
  • Fallon BA, Keilp JG, Corbera KM et al.A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology2008;70: 992–1003.
  • Krupp LB, Hyman LG, Grimson R et al.Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology2003;60: 1923–1930.
  • Marques A, Telford SR 3rd, Turk SP, et al.Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study. Clin Infect Dis2014;58: 937–945.
  • Brorson O, Brorson SH, Scythes J, MacAllister J, Wier A, Margulis L.Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci USA2009;106: 18656–18661.
  • Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL.Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation2008;5: 40.
  • Lantos PM, Auwaerter PG, Wormser GP.A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis2014;58: 663–671.
  • Sapi E, Kaur N, Anyanwu S et al.Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist2011;4: 97–113.
  • Hunfeld KP, Brade V.Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr2006;118: 659–668.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement.Wayne: CLSI, 2007.
  • Chong CR, Chen X, Shi L, Liu JO, Sullivan DJ Jr.A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol2006;2: 415–416.
  • Dever LL, Jorgensen JH, Barbour AG.In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol1992;30: 2692–2697.
  • Boerner J, Failing K, Wittenbrink MM.In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values. Zentralbl Bakteriol1995;283: 49–60.
  • Brorson O, Brorson SH.An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. Apmis1999;107: 566–576.
  • Zhang Y.The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol2005;45: 529–564.
  • Zhang Y, Yew WW, Barer MR.Targeting persisters for tuberculosis control. Antimicrob Agents Chemother2012;56: 2223–2230.
  • Zhang Y.Persisters, Persistent Infections and the Yin-Yang Model. Emerg Microbes Infect2014;3: e3.
  • Pogliano J, Pogliano N, Silverman JA.Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol2012;194: 4494–4504.
  • Kersten A, Poitschek C, Rauch S, Aberer E.Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother1995;39: 1127–1133.
  • Ates L, Hanssen-Hubner C, Norris DE, Richter D, Kraiczy P, Hunfeld KP.Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi. Ticks Tick Borne Dis2010;1: 30–34.
  • Arbiser JL, Moschella SL.Clofazimine: a review of its medical uses and mechanisms of action. J Am Acad Dermatol1995;32: 241–247.
  • Cholo MC, Steel HC, Fourie PB, Germishuizen WA, Anderson R.Clofazimine: current status and future prospects. J Antimicrob Chemother2012;67: 290–298.
  • Baginski MCJ.Amphotericin B and its new derivatives - mode of action. Curr Drug Metab2009;10: 459–469.
  • LaRocca TJ, Pathak P, Chiantia S et al.Proving lipid rafts exist: membrane domains in the prokaryote Borrelia burgdorferi have the same properties as eukaryotic lipid rafts. PLoS Pathog2013;9: e1003353.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.